Financials data is unavailable for this security.
View more
Year on year Theratechnologies Inc has grown net income from a loss of -47.24m to a smaller loss of -23.96m despite relatively flat revenues.
Gross margin | 76.97% |
---|---|
Net profit margin | -3.75% |
Operating margin | 10.72% |
Return on assets | -5.00% |
---|---|
Return on equity | -- |
Return on investment | -- |
More ▼
Cash flow in USDView more
In 2023, Theratechnologies Inc increased its cash reserves by 42.93%, or 10.24m. Cash Flow from Financing totalled 14.78m or 18.07% of revenues. In addition the company used 5.68m for operations while cash from investing totalled 1.11m.
Cash flow per share | -0.0097 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -0.5952 |
---|---|
Tangible book value per share | -0.9405 |
More ▼
Balance sheet in USDView more
Current ratio | 1.08 |
---|---|
Quick ratio | 0.9691 |
Total debt/total equity | -- |
---|---|
Total debt/total capital | 1.52 |
More ▼